Overview
Adam Vogt is a Laboratory Medicine provider in Opelika, Alabama. Dr. Vogt is highly rated in 4 conditions, according to our data. His top areas of expertise are Extramammary Paget Disease, Squamous Cell Skin Carcinoma, Bowen's Disease, and Basal Cell Skin Cancer.
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
Locations
2000 Pepperell Pkwy, Opelika, AL 36801
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Martin Army Community Hospital
Lynn Messersmith is a primary care provider, practicing in Laboratory Medicine in Fort Benning, Georgia. Her top areas of expertise are Peutz-Jeghers Syndrome, HIV/AIDS, and Melasma.
Frequently Asked Questions about Dr. Adam Vogt
How do I make an appointment with Dr. Adam Vogt?
You can book an appointment with Dr. Adam Vogt by calling their office at 719-648-5438. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Adam Vogt a top-rated expert for Extramammary Paget Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Adam Vogt is classified as an Advanced expert for Extramammary Paget Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Adam Vogt specialize in?
While Dr. Adam Vogt is a Laboratory Medicine, they have specific expertise in Extramammary Paget Disease, Squamous Cell Skin Carcinoma, and Bowen's Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Laboratory Medicine.
Does Dr. Adam Vogt participate in research or clinical trials?
Yes. Dr. Adam Vogt has published 3 articles and abstracts on conditions like Extramammary Paget Disease. You can view a list of Dr. Adam Vogt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Adam Vogt accept my insurance?
Dr. Adam Vogt accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 719-648-5438 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Basal Cell Skin CancerDr. Vogt isAdvanced. Learn about Basal Cell Skin Cancer.
- Bowen's DiseaseDr. Vogt isAdvanced. Learn about Bowen's Disease.
- Extramammary Paget DiseaseDr. Vogt isAdvanced. Learn about Extramammary Paget Disease.
- Squamous Cell Skin CarcinomaDr. Vogt isAdvanced. Learn about Squamous Cell Skin Carcinoma.
- Experienced
- Actinic KeratosisDr. Vogt isExperienced. Learn about Actinic Keratosis.
- CellulitisDr. Vogt isExperienced. Learn about Cellulitis.
- Epidermodysplasia VerruciformisDr. Vogt isExperienced. Learn about Epidermodysplasia Verruciformis.
- Epidermoid CystDr. Vogt isExperienced. Learn about Epidermoid Cyst.
- ErythrodermaDr. Vogt isExperienced. Learn about Erythroderma.
- Familial Atypical Multiple Mole Melanoma Syndrome